TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 45 filers reported holding TG THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $342,000 | -16.0% | 7,085 | -9.2% | 0.01% | -45.5% |
| Q4 2020 | $407,000 | +6.5% | 7,807 | -45.3% | 0.02% | +10.0% |
| Q3 2020 | $382,000 | +59.2% | 14,270 | +15.8% | 0.02% | +25.0% |
| Q2 2020 | $240,000 | +86.0% | 12,320 | -5.4% | 0.02% | +45.5% |
| Q1 2020 | $129,000 | +12.2% | 13,020 | +25.2% | 0.01% | +10.0% |
| Q4 2019 | $115,000 | +98.3% | 10,400 | +1.0% | 0.01% | +66.7% |
| Q3 2019 | $58,000 | -35.6% | 10,300 | -1.0% | 0.01% | -40.0% |
| Q2 2019 | $90,000 | -18.9% | 10,400 | -25.2% | 0.01% | -28.6% |
| Q1 2019 | $111,000 | +91.4% | 13,900 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $58,000 | -53.2% | 13,900 | +77.7% | 0.01% | +166.7% |
| Q4 2014 | $124,000 | -99.9% | 7,823 | -11.3% | 0.00% | -84.2% |
| Q2 2014 | $82,848,000 | +89952.2% | 8,823 | -33.9% | 0.02% | -32.1% |
| Q1 2014 | $92,000 | +64.3% | 13,347 | +19.2% | 0.03% | +47.4% |
| Q3 2013 | $56,000 | -22.2% | 11,194 | 0.0% | 0.02% | -20.8% |
| Q2 2013 | $72,000 | – | 11,194 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |